EDGAR Filing Documents for 0001193125-22-187527

Form 8-K - Current report:

SEC Accession No. 0001193125-22-187527

Filing Date

2022-07-05

Accepted

2022-07-05 07:07:06

Documents

Period of Report

2022-07-03

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d339682d8k.htm iXBRL	8-K	63453
2	EX-2.1	d339682dex21.htm	EX-2.1	565724
3	EX-4.1	d339682dex41.htm	EX-4.1	106795
4	EX-4.2	d339682dex42.htm	EX-4.2	78118
5	EX-10.1	d339682dex101.htm	EX-10.1	48482
6	EX-10.2	d339682dex102.htm	EX-10.2	48271
7	EX-10.3	d339682dex103.htm	EX-10.3	22956
8	EX-10.4	d339682dex104.htm	EX-10.4	203480
9	EX-10.5	d339682dex105.htm	EX-10.5	157478
10	EX-10.6	d339682dex106.htm	EX-10.6	74533
11	EX-10.7	d339682dex107.htm	EX-10.7	35243
12	EX-99.1	d339682dex991.htm	EX-99.1	32383
	Complete submission text file	0001193125-22-187527.txt		1901487

Data Files

Seq	Description	Document	Type	Size
13	XBRL TAXONOMY EXTENSION SCHEMA	syrs-20220703.xsd	EX-101.SCH	2850
14	XBRL TAXONOMY EXTENSION LABEL LINKBASE	syrs-20220703_lab.xml	EX-101.LAB	17235
15	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	syrs-20220703_pre.xml	EX-101.PRE	10808
17	EXTRACTED XBRL INSTANCE DOCUMENT	d339682d8k_htm.xml	XML	3225

Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140

Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340

Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)